Jonathan Welti

5.5k total citations
15 papers, 1.9k citations indexed

About

Jonathan Welti is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jonathan Welti has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Jonathan Welti's work include Angiogenesis and VEGF in Cancer (5 papers), Renal cell carcinoma treatment (4 papers) and Skin and Cellular Biology Research (3 papers). Jonathan Welti is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Renal cell carcinoma treatment (4 papers) and Skin and Cellular Biology Research (3 papers). Jonathan Welti collaborates with scholars based in United Kingdom, United States and Belgium. Jonathan Welti's co-authors include Peter Carmeliet, Sonja Loges, Stefanie Dimmeler, Andrew R. Reynolds, Morgane Gourlaouen, Johann S. de Bono, Jun Luo, Roberta Ferraldeschi, Gerhardt Attard and Adam Sharp and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jonathan Welti

15 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Welti United Kingdom 14 1.2k 593 464 445 292 15 1.9k
Aleksandra Franovic United States 18 1.3k 1.0× 744 1.3× 336 0.7× 600 1.3× 174 0.6× 38 2.0k
Qunsheng Ji China 25 1.5k 1.2× 560 0.9× 538 1.2× 686 1.5× 152 0.5× 50 2.5k
Paul Meltzer United States 7 1.8k 1.4× 824 1.4× 235 0.5× 768 1.7× 256 0.9× 10 2.4k
Anna B. Glinskii United States 18 1.5k 1.2× 583 1.0× 408 0.9× 694 1.6× 109 0.4× 22 2.2k
Danfang Zhang China 30 1.7k 1.4× 1.1k 1.8× 282 0.6× 861 1.9× 171 0.6× 65 2.4k
Oskar W. Rokhlin United States 26 1.4k 1.1× 583 1.0× 347 0.7× 557 1.3× 101 0.3× 49 2.0k
William M. Merritt United States 29 1.7k 1.4× 700 1.2× 315 0.7× 1.0k 2.3× 247 0.8× 38 3.1k
Nila U. Parikh United States 26 1.5k 1.2× 522 0.9× 314 0.7× 1.2k 2.8× 163 0.6× 39 2.5k
Mohanraj Dhanabal United States 20 2.1k 1.7× 1.3k 2.2× 268 0.6× 537 1.2× 649 2.2× 28 3.0k
Bernardo Tavora United Kingdom 14 921 0.7× 528 0.9× 226 0.5× 259 0.6× 249 0.9× 16 1.4k

Countries citing papers authored by Jonathan Welti

Since Specialization
Citations

This map shows the geographic impact of Jonathan Welti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Welti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Welti more than expected).

Fields of papers citing papers by Jonathan Welti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Welti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Welti. The network helps show where Jonathan Welti may publish in the future.

Co-authorship network of co-authors of Jonathan Welti

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Welti. A scholar is included among the top collaborators of Jonathan Welti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Welti. Jonathan Welti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Paschalis, Alec, Adam Sharp, Jonathan Welti, et al.. (2018). Alternative splicing in prostate cancer. Nature Reviews Clinical Oncology. 15(11). 663–675. 135 indexed citations
2.
3.
Bridgeman, Victoria L., Elaine Y. Wan, Shane Foo, et al.. (2015). Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 15(1). 172–183. 38 indexed citations
4.
Ferraldeschi, Roberta, Jonathan Welti, Jun Luo, Gerhardt Attard, & Johann S. de Bono. (2014). Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects. Oncogene. 34(14). 1745–1757. 140 indexed citations
5.
Welti, Jonathan, Sonja Loges, Stefanie Dimmeler, & Peter Carmeliet. (2013). Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. Journal of Clinical Investigation. 123(8). 3190–3200. 481 indexed citations
6.
Gourlaouen, Morgane, Jonathan Welti, Naveen Vasudev, & Andrew R. Reynolds. (2013). Essential Role for Endocytosis in the Growth Factor-stimulated Activation of ERK1/2 in Endothelial Cells. Journal of Biological Chemistry. 288(11). 7467–7480. 56 indexed citations
7.
Eelen, Guy, Bert Cruys, Jonathan Welti, Katrien De Bock, & Peter Carmeliet. (2013). Control of vessel sprouting by genetic and metabolic determinants. Trends in Endocrinology and Metabolism. 24(12). 589–596. 53 indexed citations
8.
Baker, Ann‐Marie, D. K. Bird, Jonathan Welti, et al.. (2012). Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis. Cancer Research. 73(2). 583–594. 118 indexed citations
9.
Welti, Jonathan, Thomas Powles, Shane Foo, et al.. (2012). Contrasting effects of sunitinib within in vivo models of metastasis. Angiogenesis. 15(4). 623–641. 58 indexed citations
10.
Sharpe, Rachel, Alex Pearson, María Teresa Herrera-Abreu, et al.. (2011). FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo. Clinical Cancer Research. 17(16). 5275–5286. 144 indexed citations
11.
Welti, Jonathan, Morgane Gourlaouen, Thomas Powles, et al.. (2010). Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib. Oncogene. 30(10). 1183–1193. 106 indexed citations
12.
Byrne, Carolyn, Ariel A. Avilion, Ryan F.L. O’Shaughnessy, Jonathan Welti, & Matthew J. Hardman. (2009). Whole-Mount Assays for Gene Induction and Barrier Formation in the Developing Epidermis. Methods in molecular biology. 585. 271–286. 13 indexed citations
13.
O’Shaughnessy, Ryan F.L., Jonathan Welti, Katherine Sully, & Carolyn Byrne. (2009). Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development. Development. 136(20). 3423–3431. 36 indexed citations
14.
Reynolds, Andrew R., Ian R. Hart, Alan R. Watson, et al.. (2009). Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nature Medicine. 15(4). 392–400. 390 indexed citations
15.
O’Shaughnessy, Ryan F.L., Jonathan Welti, James C. Cooke, et al.. (2007). AKT-dependent HspB1 (Hsp27) Activity in Epidermal Differentiation. Journal of Biological Chemistry. 282(23). 17297–17305. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026